184 related articles for article (PubMed ID: 31927783)
21. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases.
Cauchy F; Aussilhou B; Dokmak S; Fuks D; Gaujoux S; Farges O; Faivre S; Lepillé D; Belghiti J
Ann Surg; 2012 Nov; 256(5):746-52; discussion 752-4. PubMed ID: 23095618
[TBL] [Abstract][Full Text] [Related]
22. What is a safe future liver remnant size in patients undergoing major hepatectomy for colorectal liver metastases and treated by intensive preoperative chemotherapy?
Narita M; Oussoultzoglou E; Fuchshuber P; Pessaux P; Chenard MP; Rosso E; Nobili C; Jaeck D; Bachellier P
Ann Surg Oncol; 2012 Aug; 19(8):2526-38. PubMed ID: 22395987
[TBL] [Abstract][Full Text] [Related]
23. Significance of R1 Resection for Advanced Colorectal Liver Metastases in the Era of Modern Effective Chemotherapy.
Laurent C; Adam JP; Denost Q; Smith D; Saric J; Chiche L
World J Surg; 2016 May; 40(5):1191-9. PubMed ID: 26757718
[TBL] [Abstract][Full Text] [Related]
24. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?
Adam R; de Haas RJ; Wicherts DA; Aloia TA; Delvart V; Azoulay D; Bismuth H; Castaing D
J Clin Oncol; 2008 Aug; 26(22):3672-80. PubMed ID: 18669451
[TBL] [Abstract][Full Text] [Related]
25. Indications for conversion hepatectomy for initially unresectable colorectal cancer with liver metastasis.
Sugiyama M; Uehara H; Shin Y; Shiokawa K; Fujimoto Y; Mano Y; Komoda M; Nakashima Y; Sugimachi K; Yamamoto M; Morita M; Toh Y
Surg Today; 2022 Apr; 52(4):633-642. PubMed ID: 34762175
[TBL] [Abstract][Full Text] [Related]
26. Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
Maeda Y; Shinohara T; Nagatsu A; Futakawa N; Hamada T
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S242-8. PubMed ID: 25749931
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.
Passot G; Chun YS; Kopetz SE; Overman MJ; Conrad C; Aloia TA; Vauthey JN
Eur J Surg Oncol; 2016 Sep; 42(9):1378-84. PubMed ID: 27358198
[TBL] [Abstract][Full Text] [Related]
28. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
[TBL] [Abstract][Full Text] [Related]
30. Hepatic atrophy following preoperative chemotherapy predicts hepatic insufficiency after resection of colorectal liver metastases.
Yamashita S; Shindoh J; Mizuno T; Chun YS; Conrad C; Aloia TA; Vauthey JN
J Hepatol; 2017 Jul; 67(1):56-64. PubMed ID: 28192187
[TBL] [Abstract][Full Text] [Related]
31. Radiologic and pathologic response to neoadjuvant chemotherapy predicts survival in patients undergoing the liver-first approach for synchronous colorectal liver metastases.
Berardi G; De Man M; Laurent S; Smeets P; Tomassini F; Ariotti R; Hoorens A; van Dorpe J; Varin O; Geboes K; Troisi RI
Eur J Surg Oncol; 2018 Jul; 44(7):1069-1077. PubMed ID: 29615295
[TBL] [Abstract][Full Text] [Related]
32. Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery?
Vigano L; Darwish SS; Rimassa L; Cimino M; Carnaghi C; Donadon M; Procopio F; Personeni N; Del Fabbro D; Santoro A; Torzilli G
Ann Surg Oncol; 2018 Jun; 25(6):1676-1685. PubMed ID: 29488188
[TBL] [Abstract][Full Text] [Related]
33. Perioperative chemotherapy for resectable colorectal liver metastases: Analysis from the Colorectal Operative Liver Metastases International Collaborative (COLOMIC).
Gawdi R; Valenzuela CD; Moaven O; Stauffer JA; Del Piccolo NR; Cheung T; Corvera CU; Wisneski AD; Cha C; Russell G; Zarandi N; Dourado J; Shen P
J Surg Oncol; 2022 Aug; 126(2):339-347. PubMed ID: 35429409
[TBL] [Abstract][Full Text] [Related]
34. Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go?
Ihnát P; Vávra P; Zonča P
World J Gastroenterol; 2015 Jun; 21(22):7014-21. PubMed ID: 26078580
[TBL] [Abstract][Full Text] [Related]
35. Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, STROBE-Compliant, Single-Center Study Comparing Chemotherapy Alone and Combination Chemotherapy With Cetuximab or Bevacizumab.
Basso M; Dadduzio V; Ardito F; Lombardi P; Strippoli A; Vellone M; Orlandi A; Rossi S; Cerchiaro E; Cassano A; Giuliante F; Barone C
Medicine (Baltimore); 2016 May; 95(20):e3722. PubMed ID: 27196492
[TBL] [Abstract][Full Text] [Related]
36. A systematic review of repeat hepatectomy for recurrent colorectal liver metastases.
Lam VW; Pang T; Laurence JM; Johnston E; Hollands MJ; Pleass HC; Richardson AJ
J Gastrointest Surg; 2013 Jul; 17(7):1312-21. PubMed ID: 23525970
[TBL] [Abstract][Full Text] [Related]
37. Repeat Hepatectomy for Recurrent Colorectal Liver Metastases: Is it Worth the Challenge?
Ali MA; Di Sandro S; Lauterio A; Concone G; Mangoni I; Ferla F; Rotiroti V; Cusumano C; Giacomoni A; De Carlis L
J Gastrointest Surg; 2015 Dec; 19(12):2192-8. PubMed ID: 26361773
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemotherapy for resectable colorectal liver metastases: what is the evidence? Results of a systematic review of comparative studies.
Nigri G; Petrucciani N; Ferla F; La Torre M; Aurello P; Ramacciato G
Surgeon; 2015 Apr; 13(2):83-90. PubMed ID: 25257725
[TBL] [Abstract][Full Text] [Related]
39. mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival.
Yasuno M; Uetake H; Ishiguro M; Mizunuma N; Komori T; Miyata G; Shiomi A; Kagimura T; Sugihara K
Int J Clin Oncol; 2019 May; 24(5):516-525. PubMed ID: 30612267
[TBL] [Abstract][Full Text] [Related]
40. Conversion chemotherapy followed by hepatic resection in colorectal cancer with initially unresectable liver-limited metastases.
Galizia G; De Vita F; Lieto E; Zamboli A; Morgillo F; Castellano P; Mabilia A; Auricchio A; Renda A; Ciardiello F; Orditura M
Oncol Rep; 2013 Dec; 30(6):2992-8. PubMed ID: 24126855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]